Paliperidone Extended-Release: Safety and Tolerability from a Metabolic Profile Perspective-Reference-Cited by-同舟云学术

Paliperidone Extended-Release: Safety and Tolerability from a Metabolic Profile Perspective

Published:2013-10-25 Issue:12 Volume:33 Page:867-876
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clin Drug Investig

Author:

Rodríguez-Martínez Alfonso,Quilo Carlos Guzmán

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s40261-013-0100-2.pdf

Reference55 articles.

1. Andreasen NC. Symptoms, signs, and diagnosis of schizophrenia. Lancet. 1995;346(8973):477–81.

2. Buckley PF. Treatment of schizophrenia: let’s talk dollars and sense. Am J Manag Care. 1998;4(3):369–83.

3. Bishara D, Taylor D. Upcoming agents for the treatment of schizophrenia: mechanism of action, efficacy and tolerability. Drugs. 2008;68(16):2269–92.

4. Lehman AF, Lieberman JA, Dixon LB, et al. Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry. 2004;161(2 Suppl):1–56.

5. Ellenbroek BA. Treatment of schizophrenia: a clinical and preclinical evaluation of neuroleptic drugs. Pharmacol Ther. 1993;57(1):1–78.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. STUDY ON TOLERABILITY AND EFFICACY OF PALIPERIDONE PALMITATE, OLANZAPINE PAMOATE AND RISPERIDONE LONG ACTING INJECTION IN A ROMANIAN SAMPLE OF PATIENTS WITH SCHIZOPHRENIA;FARMACIA;2020-04-15

2. Modeling of prolactin response following dopamine D2 receptor antagonists in rats: can it be translated to clinical dosing?;Pharmacology Research & Perspectives;2017-11-21

3. Pharmacokinetic drug evaluation of paliperidone in the treatment of schizoaffective disorder;Expert Opinion on Drug Metabolism & Toxicology;2017-07-12

4. Paliperidone for the treatment of schizophrenia and schizoaffective disorders - a drug safety evaluation;Expert Opinion on Drug Safety;2017-02-09

5. An update of safety of clinically used atypical antipsychotics;Expert Opinion on Drug Safety;2016-07-04